Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03819686 · ClinicalTrials.gov registry record · NA
Reducing Disparities in Living Donor Transplant Among African Americans
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 416
- Enrollment target
NCT03819686 is a NA study that has completed, run by Emory University. The registered enrollment target is 416 participants.
The verdict
NCT03819686, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 416 participants
- Enrollment target
Study Summary
For most of the patients in the United States with end stage renal disease (ESRD), kidney transplantation represents the optimal treatment, and living donor kidney transplantation (LDKT) is preferable. Nevertheless, there are pervasive racial disparities in access to LDKT. The main outcome of this study is change in the proportion of study participants who have at least one living donor inquiry by friends/family over study period.The long-term objective is to understand the combined effect of a systems-level intervention (Transplant Referral EXchange or T-REX) and a culturally-sensitive individual-level educational intervention (web-based Living ACTS: About Choices in Transplantation and Sharing) on racial disparities in access to LDKT.
Interventions
- BEHAVIORAL Living ACTS website
- BEHAVIORAL Standard transplant education procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2024-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03819686
The ClinicalTrials.gov registry entry for NCT03819686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 416 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Living ACTS website is the first listed.
NCT03819686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03819686 about?
NCT03819686 is a clinical study titled "Reducing Disparities in Living Donor Transplant Among African Americans". For most of the patients in the United States with end stage renal disease (ESRD), kidney transplantation represents the optimal treatment, and living donor kidney transplantation (LDKT) is preferable. Nevertheless, there are pervasive racial disparities in access to LDKT. The main outcome of this s...
What is the current status of trial NCT03819686?
This trial is currently completed. It is a NA study. The enrollment target is 416 participants. The study started on 2019-02-04. Estimated completion is 2024-01-26.
What interventions are being tested in trial NCT03819686?
The interventions under investigation include: Living ACTS website (BEHAVIORAL), Standard transplant education procedures (BEHAVIORAL).
Who is sponsoring clinical trial NCT03819686?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.